Estados Unidos - inglés - NLM (National Library of Medicine)

a-s medication solutions - ethambutol hydrochloride (unii: qe4vw5fo07) (ethambutol - unii:8g167061qz) - ethambutol hydrochloride is indicated for the treatment of pulmonary tuberculosis. it should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety and appropriate in-vitro susceptibility studies. in patients who have not received previous antituberculous therapy, i.e., initial treatment, the most frequently used regimens have been the following: - ethambutol plus isoniazid - ethambutol plus isoniazid plus streptomycin. in patients who have received previous antituberculous therapy, mycobacterial resistance to other drugs used in initial therapy is frequent. consequently, in such retreatment patients, ethambutol should be combined with at least one of the second line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in-vitro studies. antituberculous drugs used

Estados Unidos - inglés - NLM (National Library of Medicine)

a-s medication solutions - ethambutol hydrochloride (unii: qe4vw5fo07) (ethambutol - unii:8g167061qz) - ethambutol hydrochloride tablets, usp are indicated for the treatment of pulmonary tuberculosis. it should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety, and appropriate in vitro susceptibility studies. in patients who have not received previous antituberculous therapy, i.e., initial treatment, the most frequently used regimens have been the following: ethambutol hydrochloride, usp plus isoniazid ethambutol hydrochloride, usp plus isoniazid plus streptomycin in patients who have received previous antituberculous therapy, mycobacterial resistance to other drugs used in initial therapy is frequent. consequently, in such retreatment patients, ethambutol hydrochloride should be combined with at least one of the second line drugs not previously administered to the patient and to which bacterial susceptibility has been

Kenia - inglés - Pharmacy and Poisons Board

macleods pharmaceuticals limited atlanta arcade church road near leela hotel - pyrazinamide tablets 500 mg - tablet - each uncoated tablets contain pyrazinamide bp...… - antimycobacterials: other drugs for treatment of

Filipinas - inglés - FDA (Food And Drug Administration)

n/a; importer: n/a; distributor: n/a - pyrazinamide - tablet - 500mg

Filipinas - inglés - FDA (Food And Drug Administration)

tgp pharma inc., - pyrazinamide - tablet - 500mg

Filipinas - inglés - FDA (Food And Drug Administration)

natrapharm, inc. - pyrazinamide - suspension - 500 mg/5 ml

Filipinas - inglés - FDA (Food And Drug Administration)

hexagon pharmaceuticals ltd.; distributor: hexagon pharmaceuticals ltd. - pyrazinamide - tablet - 500 mg

Filipinas - inglés - FDA (Food And Drug Administration)

unilab, inc. - pyrazinamide - suspension - 500 mg/ 5 ml

Filipinas - inglés - FDA (Food And Drug Administration)

firstmed theraconcept, inc. - pyrazinamide - tablet - 500 mg

Filipinas - inglés - FDA (Food And Drug Administration)

philrx pharma inc.; distributor: philrx pharma inc. - ascorbic acid , zinc - capsule - 500 mg (equivalent to 568.18 mg sodium ascorbate)/10 mg (equivalent to 27.50 mg zinc sulfate monohydrate)